Our aim is to transform molecular testing from a send-out, specialized test, to an affordable screening and monitoring test available everywhere people receive care.
Daktari Virology rethinks the standard paradigm for detecting and quantifying viruses. Leveraging our expertise and proprietary technology in microfluidics and electrochemical sensing, Daktari Virology brings robustness and simplicity to the point of care.
Daktari HCV and Daktari HIV are both currently in development.
Hepatitis C Virus (HCV) affects 150 million people worldwide. New treatments have transformed our ability to control and cure HCV; billions of dollars are being spent to combat hepatitis C worldwide. The need for simple, affordable HCV viral load testing to screen, stage, and monitor patients becomes a critical question. Daktari HCV will provide an answer.
HIV affects 35 million people worldwide.The World Health Organization now recommends HIV viral load testing for patient monitoring everywhere in the world. Daktari HIV for viral load testing will be the next product in Daktari’s platform for HIV care.
Tests on the Daktari Virology platform run on a single drop of blood from fingerstick or venous collection on a battery-powered portable instrument. Daktari’s microfluidic expertise eliminates the need for sample preparation; all reagents are heat-stable and contained in the disposable assay cartridge. Daktari’s billion-fold electrochemical amplification and detection technology eliminate complex optics. The result: a robust, easy-to-use instrument, and viral load test results in 30 minutes.